Polydex Pharmaceuticals Ltd - ESG Rating & Company Profile powered by AI
The report of Polydex Pharmaceuticals Ltd leverages intelligence from across the web as well as from public filings by Polydex Pharmaceuticals Ltd. The Disclosure score covers 17 UN SDGs including: 'No Poverty', 'Sustainable Cities & Communities' and 'Life below Water'. Detailed ESG analysis of Polydex Pharmaceuticals Ltd are accessed by registering for free.
Polydex Pharmaceuticals Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.9; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.7.
0.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1810 | XBiotech Inc | 1.1 | Low |
| 1826 | Mitsubishi Tanabe Pharma Corp | 1.0 | Low |
| 1827 | Polydex Pharmaceuticals Ltd | 0.9 | Low |
| 1827 | CannTrust Holdings Inc | 0.9 | Low |
| 1827 | Cannabis Poland SA | 0.9 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Polydex Pharmaceuticals Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd report the average age of the workforce?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd offer flexible work?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd conduct supply chain audits?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose water use targets?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Polydex Pharmaceuticals Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Polydex Pharmaceuticals Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Polydex Pharmaceuticals Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose its waste policy?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose energy use targets?
Sign up for free to unlockDoes Polydex Pharmaceuticals Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Polydex Pharmaceuticals Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Polydex Pharmaceuticals Ltd
These potential risks are based on the size, segment and geographies of the company.
Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry. In addition, the company develops Ushercell, a high molecular weight cellulose sulphate for topical vaginal use primarily in the prevention and transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies; and Usherdex 4, a low molecular weight dextran product to treat cystic fibrosis, a genetic disease. Further, it supplies ferric hydroxide and hydrogenated dextran solutions. The company sells its products through independent distributors and wholesalers, as well as directly to companies. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited in March 1984. Polydex Pharmaceuticals Limited was incorporated in 1979 and is based in Toronto, Canada.